| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/18/2011 | EP2322199A1 Growth differentiation factor receptors, and methods of using same |
| 05/18/2011 | EP2321422A2 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 05/18/2011 | EP2321356A2 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
| 05/18/2011 | EP2321355A1 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 05/18/2011 | EP2321354A1 Methods for identifying immunobinders of cell-surface antigens |
| 05/18/2011 | EP2321353A1 Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof |
| 05/18/2011 | EP2321352A1 Compositions monovalent for cd28 binding and methods of use |
| 05/18/2011 | EP2321351A2 Antibodies to ccr2 |
| 05/18/2011 | EP2321350A1 Antibodies against human epo receptor |
| 05/18/2011 | EP2321349A2 Cross-reactive and bispecific anti-el 17a/f antibodies |
| 05/18/2011 | EP2321348A2 Method of promoting neurogenesis |
| 05/18/2011 | EP2321347A1 Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara) |
| 05/18/2011 | EP2321345A1 Multi-specific binding proteins targeting b cell disorders |
| 05/18/2011 | EP2321338A1 Methods for purifying antibodies using protein a affinity chromatography |
| 05/18/2011 | EP2320942A2 Diagnostic antibody assay |
| 05/18/2011 | EP2164516B9 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 05/18/2011 | EP2089433B1 Therapy targeting cathepsin s |
| 05/18/2011 | EP2041181B1 Specific protease inhibitors and their use in cancer therapy |
| 05/18/2011 | EP1966245B1 Anti-cd19 antibodies with reduced immunogenicity |
| 05/18/2011 | EP1910420B1 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 05/18/2011 | EP1833850B9 Framework residue substituted humanized col-1 antibodies and their use |
| 05/18/2011 | EP1732950B1 Antibodies to erythropoietin receptor and uses thereof |
| 05/18/2011 | EP1662007B1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/18/2011 | EP1565559B1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/18/2011 | EP1558277B1 Treatment of inflammatory bowel disease |
| 05/18/2011 | EP1478764B1 Humanized collagen antibodies and related methods |
| 05/18/2011 | EP1370674B1 Enzymes having alpha amylase activity and methods of use thereof |
| 05/18/2011 | EP1356298B1 Diagnosis of disease |
| 05/18/2011 | EP1305422B1 2,5-dkg permeases |
| 05/18/2011 | EP1032595B1 Nucleic acids involved in the responder phenotype and applications thereof |
| 05/18/2011 | CN1961002B Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/18/2011 | CN102066552A Cellular production of glucaric acid |
| 05/18/2011 | CN102066420A 1d05 pcsk9 antagonists |
| 05/18/2011 | CN102066419A Humanized anti-factor D antibodies and uses thereof |
| 05/18/2011 | CN102066418A Anti-HIV monoclonal antibody |
| 05/18/2011 | CN102066411A Leishmania vaccine using sand fly salivary immunogen |
| 05/18/2011 | CN102062780A Polypeptide immunoassay kit and detection method thereof |
| 05/18/2011 | CN102061288A Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| 05/18/2011 | CN102061287A Anti-human ppGa1NAc-T2 monoclonal antibody and application thereof |
| 05/18/2011 | CN102060927A Monoclonal antibody capable of specifically recognizing activation of Galphaz protein and preparation method thereof |
| 05/18/2011 | CN102060926A Monoclonal antibody for specifically identifying activated protein Gao and preparation method thereof |
| 05/18/2011 | CN102060925A Interleukin-13 antibody composition |
| 05/18/2011 | CN102060924A Single domain antibody aiming at deoxynivalenol (DON) |
| 05/18/2011 | CN102060923A Monoclonal antibody for specifically identifying activated protein Gas and preparation method thereof |
| 05/18/2011 | CN102060911A Polypeptide combined with various amyloid protein monomers simultaneously and application thereof |
| 05/18/2011 | CN101643454B Melamine hapten and antigen as well as preparation method and application thereof |
| 05/18/2011 | CN101643453B Melamine hapten and antigen as well as preparation method and application thereof |
| 05/18/2011 | CN101463088B Anti-soman antibody |
| 05/18/2011 | CN101463087B Anti-ricin antibody |
| 05/18/2011 | CN101392023B Main allergic protein of humulus pollen |
| 05/18/2011 | CN101362794B B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof |
| 05/18/2011 | CN101072875B Novel cancer antigen peptide and the use thereof |
| 05/17/2011 | US7943745 Anti-CD98 antibody |
| 05/17/2011 | US7943744 ICAM-1 binding antibodies |
| 05/17/2011 | US7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1) |
| 05/17/2011 | US7943742 Anti-αvβ6 antibodies and uses thereof |
| 05/17/2011 | US7943741 Antibodies that specifically bind to chemokine β-4 |
| 05/17/2011 | US7943740 Compositions and methods for the treatment and diagnosis of neoplastic and infectious diseases |
| 05/17/2011 | US7943728 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 05/17/2011 | US7943588 Method for preventing or treating neuropathic pain |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943358 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying |
| 05/17/2011 | US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/17/2011 | US7943334 Method of detecting allergen |
| 05/17/2011 | US7943323 by detecting whole or non-fragmented parathyroid hormone and also a large non-whole peptide fragment hormone inhibitor |
| 05/17/2011 | US7943321 Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders |
| 05/17/2011 | US7943144 Herpes simplex virus complex |
| 05/17/2011 | US7943135 Method of treatment using anti-factor D antibodies |
| 05/17/2011 | US7943134 Compositions and methods for identifying response targets and treating flavivirus infection responses |
| 05/17/2011 | US7943132 Methods of treating pain using antagonists of IL-31, IL-31RA and/or OSMRB |
| 05/17/2011 | US7943130 Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammation |
| 05/17/2011 | US7943129 Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 05/17/2011 | US7943121 comprising heavy chain and light chain variable regions, that binds to human interleukin-1 beta with a dissociation constant less than 1 pM; time-release and sustained-release drugs |
| 05/17/2011 | CA2333582C Nicotine immunogen |
| 05/17/2011 | CA2308007C Enhancer for antibody to lymphocytic tumors |
| 05/12/2011 | WO2011057200A1 Preparing hapten-specific antibodies and their application for immunodiagnostics and research |
| 05/12/2011 | WO2011057188A1 Canine anti-cd20 antibodies |
| 05/12/2011 | WO2011057120A1 Methods and composition for secretion of heterologous polypeptides |
| 05/12/2011 | WO2011057099A2 Treating basal-like genotype cancers |
| 05/12/2011 | WO2011057027A2 Method for treating heart failure with stresscopin-like peptides |
| 05/12/2011 | WO2011056997A1 Methods for affinity maturation-based antibody optimization |
| 05/12/2011 | WO2011056983A1 Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| 05/12/2011 | WO2011056721A2 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 05/12/2011 | WO2011056644A2 Anti-glp-1r antibodies and their uses |
| 05/12/2011 | WO2011056606A1 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis |
| 05/12/2011 | WO2011056600A1 Human il-23 antigen binding proteins |
| 05/12/2011 | WO2011056561A1 Methods and compositions for the generation and use of conformation-specific antibodies |
| 05/12/2011 | WO2011056494A1 Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations |
| 05/12/2011 | WO2011056234A1 Treatment for radiation-induced disorders |
| 05/12/2011 | WO2011056198A1 Monoclonal antibody binds antigen associated with human tumors |
| 05/12/2011 | WO2011055968A2 Kit for detecting bacterial infection comprising novel monoclonal antibodies |
| 05/12/2011 | WO2011055398A1 A process for the production of immunoglobulines extracted from human plasma for therapeutic use, for the neutralization of the epstein-barr virus, and the medicine containing said immunoglobulins" |
| 05/12/2011 | WO2011055088A1 Chimeric anti-ricin antibody |
| 05/12/2011 | WO2011054519A1 Glycosylated repeat-motif-molecule conjugates |
| 05/12/2011 | WO2011054315A1 Use of cyr61 protein for preparing medicine |
| 05/12/2011 | WO2011054150A1 Method of site-directed mutagenesis by overlapping pcr and use thereof in screening monoclonal antibody |
| 05/12/2011 | WO2011054112A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | WO2011054030A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | WO2011039510A8 Agents, uses and methods |
| 05/12/2011 | WO2011035205A9 Antibodies against candida, collections thereof and methods of use |